The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Measuring the societal burden of cancer: The cost of lost productivity due to premature cancer‐related mortality in Europe
Open accessAbstract
Every cancer‐related death in someone of working age represents an economic loss to society. To inform priorities for cancer control, we estimated costs of lost productivity due to premature cancer‐related mortality across Europe, for all cancers and by site, gender, region and country. Cancer deaths in 2008 were obtained from GLOBOCAN for 30 European countries across four regions. Costs were valued using the human capital approach. Years of productive life lost (YPLL) were computed by multiplying deaths between 15 and 64 years by working‐life expectancy, then by country‐, age‐ and gender‐specific annual wages, corrected for workforce participation and unemployment. Lost productivity costs due to premature cancer‐related mortality in Europe in 2008 were €75 billion. Male costs (€49 billion) were almost twice female costs (€26 billion). The most costly sites were lung (€17 billion; 23% of total costs), breast (€7 billion; 9%) and colorectum (€6 billion; 8%). Stomach cancer (in Southern and Central‐Eastern Europe) and pancreatic cancer (in Northern and Western Europe) were also among the most costly sites. The average lost productivity cost per cancer death was €219,241. Melanoma had the highest cost per death (€312,798), followed by Hodgkin disease (€306,628) and brain and CNS cancer (€288,850). Premature mortality costs were 0.58% of 2008 European gross domestic product, highest in Central‐Eastern Europe (0.81%) and lowest in Northern Europe (0.51%). Premature cancer‐related mortality costs in Europe are significant. These results provide a novel perspective on the societal cancer burden and may be used to inform priority setting for cancer control.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hanly, P. A., & Sharp, L. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-224 · Cited by 81
Self-citation
Cited by
Pandey, A., Brauer, M., Cropper, M. L., Balakrishnan, K., Mathur, P., Dey, S., Turkgulu, B., Kumar, G. A., Khare, M., Beig, G., et al. (2021) · The Lancet Planetary Health · doi:10.1016/s2542-5196(20)30298-9 · Cited by 731
Global cancer surgery: delivering safe, affordable, and timely cancer surgery
Sullivan, R., Alatise, O. I., Anderson, B. O., Audisio, R., Autier, P., Aggarwal, A., Balch, C., Brennan, M. F., Dare, A., D'Cruz, A., et al. (2015) · The Lancet Oncology · doi:10.1016/s1470-2045(15)00223-5 · Cited by 697
Global challenges and policy solutions in breast cancer control
Trapani, D., Ginsburg, O., Fadelu, T., Lin, N. U., Hassett, M., Ilbawi, A. M., Anderson, B. O., & Curigliano, G. (2022) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2022.102339 · Cited by 316
The European Hematology Association Roadmap for European Hematology Research: a consensus document
Engert, A., Balduini, C., Brand, A., Coiffier, B., Cordonnier, C., Dohner, H., de Wit, T. D., Eichinger, S., Fibbe, W., Green, T., et al. (2016) · Haematologica · doi:10.3324/haematol.2015.136739 · Cited by 81
“Lineage priming is an idea that was brought forward by scientists in Europe.”
BackgroundInfluential
Metadata
- Authors
- Hanly, P., Soerjomataram, I., & Sharp, L.
- Venue
- International Journal of Cancer
- Publisher
- Wiley
- Published
- 2014-09-04
- Volume
- 136
- Issue
- 4
- Pages
- E136-45
- ISSN
- 0020-7136 (ISSN-L)
- 1097-0215
- OpenAlex
- W1946824863
- Cited by
- 169
- References
- 1
- FWCI
- 34.42
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Measuring the societal burden of cancer: The cost of lost productivity due to premature cancer‐related mortality in Europe. https://app.cochat.ai/papers/10.1002/ijc.29105
- The paper
- Hanly, P., Soerjomataram, I., & Sharp, L. (2015). Measuring the societal burden of cancer: The cost of lost productivity due to premature cancer‐related mortality in Europe. International Journal of Cancer. https://doi.org/10.1002/ijc.29105
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.